<ѻý>Biologic for MS Linked to Reduced Vaccine Responseѻý> Ocrelizumab treatment associated with decreased humoral response Jun 01, 2018
<ѻý>PPAR-Gamma Drug May Work in MSѻý> In phase II study, drug diminished inflammatory lesions & cortical atrophy May 30, 2017
<ѻý>McDonald Criteria for MS May Incorporate CSF Testingѻý> Revision committee finds OCB testing may be useful in specific cases May 25, 2017
<ѻý>Home-Based DVD May Motivate Seniors With MS to Exerciseѻý> Patients reported improvements in physical fitness, self-confidence Jun 07, 2016
<ѻý>Studies Try to Estimate MS Drug Pricesѻý> Meds are expensive but push other costs down Jun 06, 2016
<ѻý>Lemtrada Offers Long-Term Stability in MS Patientsѻý> Mean change in EDSS score was only +0.06 Jun 05, 2016
<ѻý>Lymphopenia Risk Factors to Watch With DMFѻý> Age, race, baseline lymphocytes, overweight, & vitamin D levels included Jun 03, 2016
<ѻý>Getting a Handle on Lymphopenia With Tecfideraѻý> Label-recommended interval for lymphocyte checks may be too long. Jun 02, 2015
<ѻý>Novel MS Drug Offers Good Functional Outcomesѻý> Daclizumab HYP beats interferon for patient-centered outcomes Jun 02, 2015
<ѻý>No Surprises with Tysabri-Tecfidera Switchѻý> Discontinuation rates for both agents were in line with those seen in clinical trials Jun 01, 2015
<ѻý>Ballroom Dance a Boon to MS Patientsѻý> A small study finds ballroom dance -- waltz, salsa, foxtrot, and others -- may improve function in MS patients. May 29, 2015